Span, Paul N <br/><br/>
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.  [electronic resource] 

 -  Oncogene  Jul 2003 
 - 4898-904 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1206818  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--chemistry<br/>Cell Cycle<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Cyclin E--analysis<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymphatic Metastasis<br/>Mastectomy<br/>Mastectomy, Segmental<br/>Menopause<br/>Middle Aged<br/>Neoplasm Proteins--analysis<br/>Prognosis<br/>Proportional Hazards Models<br/>Radiotherapy, Adjuvant<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Failure